CN104651369B - Aflatoxin B1 aptamer and its application in sample Magneto separate - Google Patents

Aflatoxin B1 aptamer and its application in sample Magneto separate Download PDF

Info

Publication number
CN104651369B
CN104651369B CN201510060484.3A CN201510060484A CN104651369B CN 104651369 B CN104651369 B CN 104651369B CN 201510060484 A CN201510060484 A CN 201510060484A CN 104651369 B CN104651369 B CN 104651369B
Authority
CN
China
Prior art keywords
aflatoxin
aptamer
sample
easy
magneto separate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201510060484.3A
Other languages
Chinese (zh)
Other versions
CN104651369A (en
Inventor
王红旗
刘继红
张军锋
张玲
周玲
王建
王静
尹海燕
祁玉峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henan Academy of Agricultural Sciences
Original Assignee
Henan Academy of Agricultural Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henan Academy of Agricultural Sciences filed Critical Henan Academy of Agricultural Sciences
Priority to CN201510060484.3A priority Critical patent/CN104651369B/en
Publication of CN104651369A publication Critical patent/CN104651369A/en
Application granted granted Critical
Publication of CN104651369B publication Critical patent/CN104651369B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a kind of aflatoxin B1 aptamer and its application in sample Magneto separate, belong to biological technical field.The nucleotide sequence of aflatoxin B1 aptamer is as shown in SEQNO.1.The aflatoxin B1 aptamer of the present invention is prepared by free state target sieving Policy Filtering, has specificity good, stability is high, cost is cheap, is easy to chemical modification and synthesis, easy to use, the features such as nontoxic, it is expected to the potential reagent detected as aflatoxin in sample.The magnetism separate method based on aflatoxin B1 aptamer can be used for the detection pre-treatment of aflatoxin B1 in sample, have enrichment, catharsis, easy, quick.Compared with antibody, for aflatoxin B1 aptamer as a kind of single stranded DNA, stability is good, is easy to preserve, and is easy to modification and mark, at the same can a large amount of chemical syntheses, difference is small between batch, and cost is cheap.

Description

Aflatoxin B1 aptamer and its application in sample Magneto separate
Technical field
The invention belongs to biological technical field, more particularly to a kind of aflatoxin B1 aptamer and its in magnetic sample Application in separation.
Background technology
The pollution for influenceing mycotoxin in the Hazard factor of agricultural product quality and safety is one of most important factor.Aspergillus flavus Toxin (Aflatoxins, AF) is primarily present in peanut, corn, rice, wheat, milk, cottonseed as a kind of natural pollution source It is the general name of the similar mycotoxin of a kind of chemical constitution in various nuts and feed, two furans cumarin of category Derivative, kind more than 20 is had now been found that, mainly including B1, B2, G1, G2, M1 and M2 etc..AFB1 is to find that toxicity is most strong so far Mycotoxin, its toxicity is strong compared with potassium cyanide 10 times, strong compared with arsenic 68 times, the organ induced hepatocellular carcinoma such as main damage liver, into For the mankind's onset of liver cancer an important factor for and a kind of carcinogenic substance is regarded as by the World Health Organization.AFB1 physicochemical properties are more steady It is fixed, there is fat-soluble, high temperature resistant, hardly possible removes, and is a kind of potential serious threat to human and livestock health.Food hygiene and agriculture in the world AFB1 contents are required Inspection Index in Products Trade, and the national standard of AF allowances in food has all been formulated in countries in the world at present, because This, which carries out the identification for being directed to AFB1 and detection research, has important scientific meaning and application value.
At present, general AF detection methods are mainly divided to two major classes in the world:Chemical analysis and immunoassay.Thin layer color Spectrometry (TLC), microtrabeculae method, high performance liquid chromatography (HPLC) etc. belong to chemical analysis, these detection method high sensitivity, standards Exactness is good, but sample pre-treatments are complicated, detection is more time-consuming, instrument and equipment is relatively valuable, and has to testing staff higher Technical requirements.Enzyme linked immunosorbent assay (ELISA) is sensitive, safely, quickly, it is anti-interference, be that universal practical AF is immunized at present Detection method, but this micromolecular toxicity of AF is higher, the Antibody preparation cycle is long, technical difficulty is big, differences between batches are big, and prepares Good antibody is not easy to maintain, easy in inactivation, and these shortcomings greatly limit the popularization and fast development of immunological analysis method.Nucleic acid Aptamers, referred to as " chemical antibody ", have target scope wide (even malicious as a kind of single stranded oligonucleotide compared with antibody Property target), can external preparation, the construction cycle is short, production cost is low, it is specific it is high, stability is good, quality is homogeneous, differences between batches It is small and be easy to chemical synthesis and modification the advantages that.
At present, the Fast Detection Technique research and development based on aptamer are more and more hotter, in medical science very Extensively, and the application report in mycotoxin context of detection is also only limitted to ochratoxin A (OTA) and fumonisin B1 (FB1).Therefore, the exploitation for AF molecular recognition elements aptamer has important Research Significance and wide application The target molecule identification specificity of prospect, particularly its height (can distinguish the difference of single modification group, as the nucleic acid of theophylline is fitted Part can distinguish cocaine and theophylline molecule, and the two only has the difference of a methyl), it is especially suitable for AF this class formation extremely phase As small molecule analysis.
The content of the invention
The primary and foremost purpose of the present invention is to overcome shortcoming and deficiency present in prior art, there is provided a kind of aflatoxin B1 aptamers, the aptamer can specific recognition aflatoxin B1, its screening process uses free state target Screening strategy is that screening process holding aflatoxin B1 is free state, does not carry out any modification to it.
Another object of the present invention is to provide described aflatoxin B1 aptamer in sample Magneto separate Using.
The purpose of the present invention is achieved through the following technical solutions:A kind of aflatoxin B1 aptamer, its nucleotides Sequence is as follows:
CCTGCCACGCTCCGCAAGCTTATAGGGCACGTGTTGTCTTCCTGTGTCTCGTGCCCATCGCTAGGTTTACATAAGCT TGGCACCCGCATCGT。
Described aflatoxin B1 aptamer has secondary structure as shown in Figure 6.
Described aflatoxin B1 aptamer can apply to sample Magneto separate.
Preferably, described aflatoxin B1 aptamer can apply to aflatoxin B1 magnetic point in sample From.
Described aflatoxin B1 aptamer includes the derived sequence of amido modified above-mentioned nucleotide sequence, described Amido modified nucleotide sequence derived sequence have with aflatoxin B1 aptamer original sequence identical from sample Carry out aflatoxin B1 Magneto separate function.
Described aflatoxin B1 aptamer is applied to aflatoxin B1 Magneto separate in sample, including following step Suddenly:
(1) amido modified aflatoxin B1 aptamer is linked on the magnetic bead of carboxyl modified;
(2) magnetic bead of aflatoxin B1 aptamer and the sample extracting solution containing aflatoxin B1 will be modified with Mixing, magnetic bead is enriched with using Magneto separate frame, is washed out, finally affords the high aflatoxin B1 of purity levels.
The present invention is had the following advantages relative to prior art and effect:
1) aflatoxin B1 aptamer of the invention is obtained by free state target sieving strategy, screening process The modification of target molecules it is not related to, therefore the aflatoxin B1 aptamer obtained has preferably specificity.
2) compared with antibody, for aflatoxin B1 aptamer as a kind of single stranded DNA, stability is good, is easy to preserve, Be easy to modification and mark, at the same can a large amount of chemical syntheses, difference is small between batch, and cost is cheap.
Brief description of the drawings
Fig. 1 is fixed effect figure of the library on magnetic bead:A is Magnetic particles fluorescence microscope image;B is to be fixed with fluorescence Mark the magnetic bead fluorescence microscope image of library complexes;
Fig. 2 is screening library affinity with the screening increased situation of change result figure of round;
Fig. 3 is that screening library binding specificity investigates result figure;
Fig. 4 is cross-linking result figure of the amido modified aflatoxin B1 aptamer on magnetic bead:A is magnetic point after crosslinking From supernatant afterwards;B is the stoste before aflatoxin B1 aptamer is crosslinked;
Fig. 5 is the Magneto separate design sketch of the aptamer modified magnetic bead of aflatoxin B1:A it is) aflatoxin B1 500nM acetonitrile solution (1:1);B) the aflatoxin B1 screening buffer solution with concentration is fitted by aflatoxin B1 nucleic acid Acetonitrile solution (1 after ligand modified magnetic capture-Magneto separate-elution:1);C) for the aflatoxin B1 of concentration sieve Select buffer solution capture by Magnetic particles-Magneto separate-elution after acetonitrile solution (1:1);
Fig. 6 is the secondary structure figure of aflatoxin B1 aptamer.
Embodiment
With reference to embodiment and accompanying drawing, the present invention is described in further detail, but embodiments of the present invention are unlimited In this.
Embodiment 1
The free state target sieving of aflatoxin B1 aptamer
SELEX single stranded DNA random libraries used in the present embodiment are designed as:Both ends are primer fixed sequence program, in Between be for toward the fixed sequence program that library is fixed on magnetic bead, respectively having one section between both ends fixed sequence program and middle fixed sequence program at random Library sequence:5’-CCTGCCACGCTCCGCAAGCTT-N10-CTGCAGCGATTCTTGATCG-N20- TAAGCTTGGCACCCGCATCGT-3 ', storage capacity more than 1014.The library designs and design of traditional fixed sequence program at both ends Difference, the primer fixed sequence program at one side both ends carry out hybridization blocker using short sequence in screening process, avoid library and exist Participate in combining with primer sequence in target cohesive process, while there is bigger downstream exploitation convenience, sequence is fixed in middle library Row can introduce fluorescence labeling short chain sequence, be easy to design " configuration switches type " aptamer sensor.The primer P1: 5 '-Cy3-GCGGAGCGTGGCAGG-3, primer 2:5 '-ACGATGCGGGTGCCAAGCTTA-3 ', primer 3: 5’- CCTGCCACGCTCCGC-3 ', primer 4:5’-Biotin-TACCGCAAAAAAAAACAAGAATCGCTGCAG-3’.
First by 1nmol DNA libraries, 1.5nmol primers 1,1.5nmol primer 2s, 5nmol primers 4 in screening buffer solution In 4 DEG C of overnight hybridizations together, then the library complexes after hybridization are washed and disperseed with screening cushioning liquid in advance with 200 μ L Streptavidin modification magnetic bead at room temperature gently concussion be incubated 30min, Magneto separate remove supernatant and with screen buffer solution again Wash magnetic bead 5 times, it is respectively 1uM aflatoxin B1, B2, G1, G2 screening μ L room temperatures of buffer solution 200 to be eventually adding final concentration Under gently concussion be incubated 1h.Directly enter performing PCR amplification after reaction to the supernatant that Magneto separate obtains, the PCR primer after amplification utilizes Isopropanol precipitating method purifies the screening for being directly used in next round.It is ensuing more than ten wheel amplification, first by it is last round of obtain it is pure Change library and the primer 1,2,4 newly added heats 5min in 95 DEG C, then hybridize 30min under room temperature condition, other operations are same On.After screening carries out ten wheels, carries out independent parllel screening with aflatoxin B1, B2, G1, G2 respectively, and by target with it is literary The incubation time in storehouse shortens to 10min.Cloning and sequencing finally is carried out to satisfactory library, so as to obtain high-affinity, height Specific aflatoxin B1 aptamer.
Fixed effect of the library complexes on magnetic bead is as shown in Figure 1.Because the band of primer 1 of hybridization can be held with library 5 ' There is fluorophor, so the magnetic bead in unfixed library does not have fluorescence under fluorescence microscope, be fixed with the magnetic bead in library glimmering There is fluorescence under light microscope.
As the positive screening process containing target, negative screening is done with the screening buffer solution without aflatoxin B1, will Compared with it elutes supernatant and target elution supernatant, screening library affinity is investigated with screening the increased situation of change of round, As a result it is as shown in Figure 2.With the increase of screening round, the amount in the library that the target buffer solutions of same concentrations elutes gradually exists Increase, while the fluorescence intensity of supernatant gradually strengthens.By the screening of more than ten wheels, the amount in the library that target elutes no longer increases Add or increased comparison is slow, that is, elute the unobvious that the fluorescence intensity of supernatant no longer strengthens or strengthened, now show to sieve Process is selected to progressively reach a platform, signal screening is so far.
Make the specificity in target investigation gained library with other structures similitude small molecule, as a result as shown in Figure 3.Contain Huang Aspertoxin B1 screening buffer solution and the fluorescence for being fixed with the supernatant eluent after the magnetic bead of library fluorescent composition is incubated are strong Degree is stronger, and glimmering with being fixed with library with other structures similitude small molecule aflatoxin B 2, G1, G2 screening buffer solution The fluorescence intensity of supernatant eluent after the magnetic bead incubation of recovery compound is weaker or does not have, it was demonstrated that the screening text finally obtained Storehouse it is specific relatively good, carry out cloning and sequencing, wherein frequency of occurrences highest sequence be 5 '- CCTGCCACGCTCCGCAAGCTTATAGGGCACGTGTTGTCTTCCTGTGTCTCGTGCCCATCGCTAGGTTTACATAAGCT TGGCACCCGCATCGT-3’.Described aflatoxin B1 aptamer has secondary structure as shown in Figure 6.
Embodiment 2
Application of the aflatoxin B1 aptamer before sample Magneto separate in terms of processing
100 μ L carboxyl modifieds magnetic beads (carboxyl mark rate is more than 10 μm of ol/ μ L) Magneto separate is taken to remove dispersion liquid, then same 2- (N- morpholinoes) ethyl sulfonic acid (MES) buffer solution (25mM, pH=5) 200 μ L are mixed 10 minutes, and Magneto separate removes supernatant in triplicate, Finally disperse washed magnetic bead with 150.5 μ L MES buffer solutions, add the amido modified aflatoxin B1 nucleic acid of 9.5 μ L and fit Part (100 μM), while it is rapidly added the MES of 30 μ L1- (3- dimethylamino-propyls) -3- ethyl-carbodiimide hydrochlorides (EDC) Buffer solution (100mg/mL), sealing, lucifuge, 4 DEG C of jogs react 2h, and then Magneto separate takes supernatant to do gel electrophoresis experiment and tied Fruit identifies that cross-linking result is as shown in Figure 4.Under this cross linking conditions, the aptamer of aflatoxin B1 almost 100% is handed over It is linked on magnetic bead.500 μ L aflatoxin B1s concentration for 500nM screening buffer soln and are modified with aflatoxin B1 The magnetic bead room temperature jog reaction 10min of aptamer, is then washed 3 times with screening buffer solution, is eventually adding 500 μ L acetonitrile The aqueous solution (volume ratio 1:1) concussion elution 5min, Magneto separate take supernatant to make testing sample.Check experiment is used without nucleic acid adaptation The magnetic bead of body modification, other operations are constant the same, as a result as shown in Figure 5.It is modified with the magnetic of aflatoxin B1 aptamer Pearl separation, enrichment, the efficiency of purifying aflatoxin B1 are very high, and the rate of recovery is 90% or so;Do not modify aflatoxin B1 The magnetic bead of aptamer, only on a small quantity absorption or do not adsorb, it is impossible to capture aflatoxin B1, without separation, enrichment, Purify aflatoxin B1 the effect of, as a result prove the aptamer be expected to as in sample aflatoxin detect it is potential Reagent, the magnetism separate method based on aflatoxin B1 aptamer are expected to be used in sample before aflatoxin B1 detection Processing, there is enrichment, catharsis.
Above-described embodiment is the preferable embodiment of the present invention, but embodiments of the present invention are not by above-described embodiment Limitation, other any Spirit Essences without departing from the present invention with made under principle change, modification, replacement, combine, simplification, Equivalent substitute mode is should be, is included within protection scope of the present invention.

Claims (1)

  1. A kind of 1. application of aflatoxin B1 aptamer, it is characterised in that:Described aflatoxin B1 nucleic acid adaptation Body is applied to aflatoxin B1 Magneto separate in sample, comprises the following steps:
    (1) amido modified aflatoxin B1 aptamer is linked on the magnetic bead of carboxyl modified;
    (2) magnetic bead for being modified with aflatoxin B1 aptamer and the sample extracting solution containing aflatoxin B1 are mixed Close, be enriched with magnetic bead using Magneto separate frame, be washed out, finally afford the high aflatoxin B1 of purity levels;
    The nucleotide sequence of described aflatoxin B1 aptamer is as shown in SEQ ID NO.1.
CN201510060484.3A 2015-02-06 2015-02-06 Aflatoxin B1 aptamer and its application in sample Magneto separate Expired - Fee Related CN104651369B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510060484.3A CN104651369B (en) 2015-02-06 2015-02-06 Aflatoxin B1 aptamer and its application in sample Magneto separate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510060484.3A CN104651369B (en) 2015-02-06 2015-02-06 Aflatoxin B1 aptamer and its application in sample Magneto separate

Publications (2)

Publication Number Publication Date
CN104651369A CN104651369A (en) 2015-05-27
CN104651369B true CN104651369B (en) 2017-11-14

Family

ID=53243014

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510060484.3A Expired - Fee Related CN104651369B (en) 2015-02-06 2015-02-06 Aflatoxin B1 aptamer and its application in sample Magneto separate

Country Status (1)

Country Link
CN (1) CN104651369B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105158513A (en) * 2015-06-05 2015-12-16 江西省农业科学院农产品质量安全与标准研究所 Aptamer-modified magnetic nano material and application thereof in separating ochratoxin A
CN104959114A (en) * 2015-06-05 2015-10-07 江西省农业科学院农产品质量安全与标准研究所 Preparation and application of aptamer-magnetic nanoparticle used for enrichment and separation of aflatoxin B1
CN106970172A (en) * 2017-01-19 2017-07-21 北京美正生物科技有限公司 A kind of aflatoxin aptamers affinity column and its production and use
CN107144657B (en) * 2017-05-19 2018-08-10 南京财经大学 The preparation and application of aflatoxin B1 aptamers affinity capillary integral post
CN114807147B (en) * 2021-01-19 2023-08-15 中国科学院苏州纳米技术与纳米仿生研究所 Nucleic acid aptamer of aflatoxin B1 and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102517289A (en) * 2011-11-25 2012-06-27 国家纳米技术与工程研究院 Nucleic acid aptamer of aflatoxin B1 and application thereof
CN102952802B (en) * 2012-09-29 2014-04-30 江南大学 Group of oligonucleotides aptamers capable of specifically recognizing aflatoxin B1
CN103725686B (en) * 2014-01-14 2016-04-27 厦门大学 AFB 1aptamer AFB 1-20 and application

Also Published As

Publication number Publication date
CN104651369A (en) 2015-05-27

Similar Documents

Publication Publication Date Title
CN104651369B (en) Aflatoxin B1 aptamer and its application in sample Magneto separate
Guo et al. Aptamer-based biosensor for detection of mycotoxins
Xiao et al. Developmental trend of immunoassays for monitoring hazards in food samples: A review
Yue et al. Simultaneous detection of Ochratoxin A and fumonisin B1 in cereal samples using an aptamer–photonic crystal encoded suspension Array
Ha Recent advances for the detection of ochratoxin A
Luo et al. Fluorescent aptasensor for antibiotic detection using magnetic bead composites coated with gold nanoparticles and a nicking enzyme
Ma et al. Selection, characterization and application of aptamers targeted to Aflatoxin B2
Chen et al. Screening and identification of DNA aptamers against T-2 toxin assisted by graphene oxide
Yun et al. Aptamer-based rapid visual biosensing of melamine in whole milk
CN104630230B (en) The aptamer of one group of specific recognition okadaic acid
Yang et al. Selection and identification of a DNA aptamer for ultrasensitive and selective detection of λ-cyhalothrin residue in food
Vergara-Barberan et al. Recent advances in aptamer-based miniaturized extraction approaches in food analysis
Xi-Hui et al. Application of aptamer identification technology in rapid analysis of mycotoxins
Shan et al. Duplexed aptamer-isothermal amplification-based nucleic acid-templated copper nanoparticles for fluorescent detection of okadaic acid
Xia et al. Screening and identification of an aptamer as novel recognition molecule in the test strip and its application for visual detection of ethyl carbamate in liquor
Wen et al. Selection and truncation of aptamers as fluorescence sensing platforms for selective and sensitive detection of nitrofurazone
CN104745588A (en) Specific nucleic acid aptamer for recognizing streptomycin and application of nucleic acid aptamer to streptomycin detection
CN104480114B (en) The method of high performance liquid chromatography screening aptamer and aptamer and application
Duan et al. Ratiometric SERS aptasensing for simultaneous quantitative detection of histamine and tyramine in fishes
Tian et al. Screening strategy of aptamer and its application in food contaminants determination
Yang et al. Screening and identification of a DNA aptamer to construct the label-free fluorescent aptasensor for ultrasensitive and selective detection of clothianidin residue in agricultural products
Wang et al. An antifouling polydopamine-based fluorescent aptasensor for determination of arginine kinase
He et al. Selected ssDNA aptamers–graphene oxide‐based fluorescent biosensor to detect sulfameter in milk
Zhang et al. Ratiometric fluorescent sensor based on a truncated specific aptamer by MGO-SELEX screening for streptomycin detection
CN109797154B (en) Aptamer PQ-15 specifically bound with paraquat and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20171114

Termination date: 20220206